Overview

Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of Adapalene Gel 0.3% in the treatment of atrophic acne scars.
Phase:
Phase 2
Details
Lead Sponsor:
Galderma
Galderma R&D
Treatments:
Adapalene